Design Therapeutics, Inc. (DSGN): Price and Financial Metrics
DSGN Price/Volume Stats
| Current price | $3.98 | 52-week high | $7.77 |
| Prev. close | $4.02 | 52-week low | $2.60 |
| Day low | $3.94 | Volume | 67,700 |
| Day high | $4.07 | Avg. volume | 135,730 |
| 50-day MA | $3.79 | Dividend yield | N/A |
| 200-day MA | $0.00 | Market Cap | 225.94M |
DSGN Stock Price Chart Interactive Chart >
Design Therapeutics, Inc. (DSGN) Company Bio
Design Therapeutics, Inc. develops therapies for the treatment of degenerative disorders caused by nucleotide repeat expansions. The company engages in the development of a program for the treatment of Friedreich's ataxia and degenerative diseases such as Fragile X syndrome and myotonic dystrophy. The company was incorporated in 2017 and is based in Carlsbad, California.
DSGN Price Returns
| 1-mo | 6.42% |
| 3-mo | 0.51% |
| 6-mo | -23.17% |
| 1-year | -2.21% |
| 3-year | -79.69% |
| 5-year | N/A |
| YTD | -35.49% |
| 2024 | 132.83% |
| 2023 | -74.17% |
| 2022 | -52.08% |
| 2021 | N/A |
| 2020 | N/A |
Loading social stream, please wait...